Literature DB >> 20099348

Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.

Sooah Kim1, Lorenzo Mannelli, Cristina H Hajdu, James S Babb, Timothy W I Clark, Elizabeth M Hecht, Bachir Taouli.   

Abstract

PURPOSE: To assess the diagnostic accuracy of image subtraction compared with nonsubtracted images obtained with contrast-enhanced T1-weighted imaging (CE T1WI) for the diagnosis of hepatocellular carcinoma (HCC) necrosis after transarterial chemoembolization (TACE), using liver explant as the reference standard.
MATERIALS AND METHODS: Thirty-four patients who underwent TACE within 90 days of liver transplantation and CE MRI scans were assessed by two independent observers who determined the percentage of tumor necrosis using nonsubtracted and subtracted postcontrast phases. Histopathologic percentage of necrosis was retrospectively determined by an experienced pathologist. Spearman rank correlation test was used to correlate the percentages of necrosis from MR evaluation and from pathology. Receiver operating characteristics curve analysis was performed to determine the performance of subtracted versus nonsubtracted datasets for the diagnosis of complete tumor necrosis.
RESULTS: There were 57 HCCs (mean size, 2.4 cm; range, 1.2-4.2 cm) diagnosed at explant and identified on MRI, including 16 completely necrotic HCCs. Subtraction demonstrated better interobserver agreement than nonsubtraction dataset for the diagnosis of tumor necrosis. There was a strong correlation between image subtraction and histopathologic assessment of necrosis (r = 0.80-0.86, depending on the phase, P < 0.0001). Subtraction demonstrated significantly higher sensitivity and accuracy for the diagnosis of complete tumor necrosis compared with nonsubtracted dataset.
CONCLUSION: Image subtraction enables accurate assessment of necrosis of HCC after TACE with the best accuracy observed at the arterial phase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20099348     DOI: 10.1002/jmri.22038

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  20 in total

1.  Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy.

Authors:  Sonja Gordic; Jad Bou Ayache; Paul Kennedy; Cecilia Besa; Mathilde Wagner; Octavia Bane; Richard L Ehman; Edward Kim; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2017-06

2.  Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy.

Authors:  Nicholas R Perkons; Ryan M Kiefer; Michael C Noji; Mehrdad Pourfathi; Daniel Ackerman; Sarmad Siddiqui; David Tischfield; Enri Profka; Omar Johnson; Stephen Pickup; Anthony Mancuso; Austin Pantel; Michelle R Denburg; Gregory J Nadolski; Stephen J Hunt; Emma E Furth; Stephen Kadlecek; Terence P F Gade
Journal:  Hepatology       Date:  2020-05-16       Impact factor: 17.425

3.  Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.

Authors:  Julius Chapiro; Laura D Wood; MingDe Lin; Rafael Duran; Toby Cornish; David Lesage; Vivek Charu; Rüdiger Schernthaner; Zhijun Wang; Vania Tacher; Lynn Jeanette Savic; Ihab R Kamel; Jean-François Geschwind
Journal:  Radiology       Date:  2014-07-15       Impact factor: 11.105

4.  Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; Rüdiger Schernthaner; David Lesage; Zhijun Wang; Lynn Jeanette Savic; Jean-François Geschwind
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

5.  Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.

Authors:  David Bonekamp; Susanne Bonekamp; Vivek Gowdra Halappa; Jean-Francois H Geschwind; John Eng; Celia Pamela Corona-Villalobos; Timothy M Pawlik; Ihab R Kamel
Journal:  Eur J Radiol       Date:  2013-12-03       Impact factor: 3.528

6.  Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; Rüdiger E Schernthaner; Zhijun Wang; Boris Gorodetski; Jean-François Geschwind
Journal:  Radiology       Date:  2014-12-19       Impact factor: 11.105

7.  Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?

Authors:  Sonia Sahu; Ruediger Schernthaner; Roberto Ardon; Julius Chapiro; Yan Zhao; Jae Ho Sohn; Florian Fleckenstein; MingDe Lin; Jean-François Geschwind; Rafael Duran
Journal:  Radiology       Date:  2016-11-10       Impact factor: 11.105

8.  Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; Benedetto Mungo; Todd Schlachter; Rüdiger Schernthaner; Boris Gorodetski; Zhijun Wang; Jean François Geschwind
Journal:  Eur J Radiol       Date:  2014-12-13       Impact factor: 3.528

9.  Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria.

Authors:  Susanne Bonekamp; Zhen Li; Jean-François H Geschwind; Vivek Gowdra Halappa; Celia Pamela Corona-Villalobos; Diane Reyes; Timothy M Pawlik; David Bonekamp; John Eng; Ihab R Kamel
Journal:  Radiology       Date:  2013-04-24       Impact factor: 11.105

10.  Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.

Authors:  MingDe Lin; Olivier Pellerin; Nikhil Bhagat; Pramod P Rao; Romaric Loffroy; Roberto Ardon; Benoit Mory; Diane K Reyes; Jean-François Geschwind
Journal:  J Vasc Interv Radiol       Date:  2012-12       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.